In recent years, the peptide research field has expanded rapidly, driven by innovations in molecular biology, regenerative medicine, metabolic science, and mitochondrial health. As a result, there are increasing resources that make it easy to buy peptides online strictly for research purposes.
For academic institutions, private laboratories, and biotech firms, these compounds offer exciting possibilities for studying cellular processes, tissue regeneration, mitochondrial optimization, and metabolic modulation. Today we’ll highlight some of the most popular peptides for sale in 2025, providing an overview of their mechanisms, areas of research focus, and what makes them such compelling subjects of scientific study.
Note: All peptides discussed below are intended for laboratory research only and are not for human consumption or use.
1. Retatrutide
Overview:
Retatrutide is a novel investigational peptide that has attracted attention in research exploring energy metabolism, glucose regulation, and body weight modulation. It is a multi-receptor agonist, meaning it interacts with multiple incretin hormone receptors, specifically GLP-1, GIP, and glucagon receptors.
Key Research Points:
- GLP-1 (glucagon-like peptide-1) receptor agonism is already well-studied in metabolic and obesity research.
- GIP (glucose-dependent insulinotropic polypeptide) and glucagon receptors play additional roles in appetite signaling and energy expenditure.
- Early studies suggest that combining agonist activity at all three receptors may produce synergistic effects on weight and insulin sensitivity in preclinical models.
Why It’s Trending:
Retatrutide’s unique triagonist profile makes it a hot target for comparative studies involving other single- or dual-agonist peptides. Research labs are interested in how this combination could outperform earlier analogs when studied in metabolic models.
2. Tirzepatide
Overview:
Another standout peptide in ongoing metabolic research, Tirzepatide is a dual GIP and GLP-1 receptor agonist. It has been widely studied in models assessing glucose regulation, insulin response, and energy balance.
Key Research Points:
- Unlike traditional GLP-1 agonists, Tirzepatide also stimulates GIP receptors, potentially enhancing insulin secretion and sensitivity in test subjects.
- Researchers are particularly focused on its glucose-lowering effects and its potential for appetite modulation when administered in lab studies.
Why It’s Trending:
Tirzepatide remains one of the most frequently sourced peptides for sale in 2025 because of its robust research background and promising dual-hormone action. It serves as a benchmark for studies investigating combination incretin-based approaches to metabolic dysfunction.
3. SS-31 (Elamipretide)
Overview:
SS-31, also known as Elamipretide, is a mitochondria-targeting peptide. It is composed of a unique aromatic-cationic tetrapeptide sequence that allows it to selectively localize to the inner mitochondrial membrane.
Key Research Points:
- SS-31 interacts with cardiolipin, a phospholipid that is critical for maintaining mitochondrial structure and function.
- It has shown promise in laboratory models involving oxidative stress, mitochondrial dysfunction, and age-related cellular decline.
- Common areas of investigation include neurodegenerative conditions, cardiovascular health, and muscle energy metabolism.
Why It’s Trending:
The growing emphasis on mitochondrial health has placed SS-31 at the forefront of cell metabolism and bioenergetics research. Labs exploring interventions for mitochondrial disorders often turn to SS-31 to assess its potential to improve ATP production and reduce cellular damage in test systems.
4. BPC-157/TB-500 Blend
Overview:
The combination of BPC-157 and TB-500 has become an increasingly popular subject in regenerative medicine research. Both peptides are believed to play roles in tissue repair, cellular migration, and inflammation modulation when studied in vitro or in vivo animal models.
Key Research Points:
- BPC-157 is derived from a protein found in gastric juices and is studied for its potential to aid in vascular and tissue healing.
- TB-500 (a synthetic version of thymosin beta-4 fragment) is researched for its actin-regulating properties, which may influence cellular mobility and tissue regeneration.
- When used in tandem, researchers are interested in potential synergistic effects on musculoskeletal repair, angiogenesis, and wound healing in preclinical studies.
Why It’s Trending:
As the demand for peptides involved in soft tissue and tendon research grows, blends like BPC-157/TB-500 offer a promising avenue for comparative studies. Many labs are investigating how these peptides function individually and in combination for models of acute and chronic injury.
5. Cagrilintide
Overview:
Cagrilintide is an investigational amylin analog peptide, often studied for its effects on satiety signaling and appetite suppression. Amylin is a hormone co-secreted with insulin by pancreatic beta cells, and cagrilintide mimics this behavior.
Key Research Points:
- Researchers study Cagrilintide for its effects on food intake regulation in laboratory models.
- It has been studied alongside GLP-1 receptor agonists to explore amplified effects on appetite and weight control.
- Its long-acting profile makes it an ideal candidate for extended dosing models in animal research.
Why It’s Trending:
There is growing interest in combination therapy research involving amylin and incretin mimetics. Cagrilintide’s role in this space is unique, as it introduces another hormone pathway to the mix. In 2025, studies are increasingly focused on dual or triple peptide strategies, positioning Cagrilintide as a vital component in metabolic peptide research.
6. NAD+ (Nicotinamide Adenine Dinucleotide)
Overview:
While technically not a peptide, NAD+ is frequently available in peptide research supply catalogs due to its profound role in cellular energy metabolism and aging research. It is a coenzyme essential to redox reactions and plays a pivotal role in mitochondrial function.
Key Research Points:
- NAD+ levels decline with age, prompting research into how supplementation or stimulation affects SIRT1 activity, DNA repair, and cellular longevity.
- Labs are studying NAD+ in conjunction with peptides to evaluate synergistic effects on mitochondrial health and oxidative stress.
- Research often focuses on neuroprotection, metabolic disorders, and muscle function in animal models.
Why It’s Trending:
NAD+ remains a key molecule in longevity and bioenergetics studies. Its presence in peptide supplier catalogs speaks to the interdisciplinary overlap between enzymatic cofactors and peptide therapeutics. For many labs, NAD+ is a staple for mitochondrial optimization protocols.
The Expanding Landscape of Peptide Research
The field of peptide research is more dynamic than ever and buying peptides online has never been easier. From novel metabolic modulators like Retatrutide and Tirzepatide to mitochondrial enhancers like SS-31 and NAD+, the variety of peptides for sale in 2025 reflects a growing interest in targeted biological mechanisms. Laboratories continue to explore the possibilities these compounds offer in controlled, preclinical settings.
As new peptides are synthesized and better understood, researchers are afforded a wealth of tools to investigate critical biological systems: from energy regulation and appetite control to tissue repair and cellular longevity.
If your lab is looking for a trusted source of high-quality peptides for research use only, we invite you to explore our curated collection at Molecular Solutions Peptides. If you’re looking to buy peptides online, our catalog includes most of the peptides listed above and many more, all supplied with third-party testing and documentation to ensure purity and consistency for your scientific studies.
Disclaimer: All products on this site are for Research, Development use only. Products are Not for Human use of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.